OBJECTIVE: Schizophrenia results in cognitive impairments as well as positive, negative, and disorganized symptomatology. The present study examines the extent to which these cognitive deficits are generalized across domains, potential moderator variables, and whether the pattern of cognitive findings reported in schizophrenia has remained consistent over time and across cultural and geographic variation. METHOD: Relevant publications from 2006 to 2011 were identified through keyword searches in PubMed and an examination of reference lists. Studies were included if they (1) compared the cognitive performance of adult schizophrenia patients and healthy controls, (2) based schizophrenia diagnoses on contemporary diagnostic criteria, (3) reported information sufficient to permit effect size calculation, (4) were reported in English, and (5) reported data for neuropsychological tests falling into at least 3 distinct cognitive domains. A set of 100 non-overlapping studies was identified, and effect sizes (Hedge's g) were calculated for each cognitive variable. RESULTS: Consistent with earlier analyses, patients with schizophrenia scored significantly lower than controls across all cognitive tests and domains (grand mean effect size, g=-1.03). Patients showed somewhat larger impairments in the domains of processing speed (g=-1.25) and episodic memory (g=-1.23). Our results also showed few inconsistencies when grouped by geographic region. CONCLUSIONS: The present study extends findings from 1980 to 2006 of a substantial, generalized cognitive impairment in schizophrenia, demonstrating that this finding has remained robust over time despite changes in assessment instruments and alterations in diagnostic criteria, and that it manifests similarly in different regions of the world despite linguistic and cultural differences.
OBJECTIVE:Schizophrenia results in cognitive impairments as well as positive, negative, and disorganized symptomatology. The present study examines the extent to which these cognitive deficits are generalized across domains, potential moderator variables, and whether the pattern of cognitive findings reported in schizophrenia has remained consistent over time and across cultural and geographic variation. METHOD: Relevant publications from 2006 to 2011 were identified through keyword searches in PubMed and an examination of reference lists. Studies were included if they (1) compared the cognitive performance of adult schizophreniapatients and healthy controls, (2) based schizophrenia diagnoses on contemporary diagnostic criteria, (3) reported information sufficient to permit effect size calculation, (4) were reported in English, and (5) reported data for neuropsychological tests falling into at least 3 distinct cognitive domains. A set of 100 non-overlapping studies was identified, and effect sizes (Hedge's g) were calculated for each cognitive variable. RESULTS: Consistent with earlier analyses, patients with schizophrenia scored significantly lower than controls across all cognitive tests and domains (grand mean effect size, g=-1.03). Patients showed somewhat larger impairments in the domains of processing speed (g=-1.25) and episodic memory (g=-1.23). Our results also showed few inconsistencies when grouped by geographic region. CONCLUSIONS: The present study extends findings from 1980 to 2006 of a substantial, generalized cognitive impairment in schizophrenia, demonstrating that this finding has remained robust over time despite changes in assessment instruments and alterations in diagnostic criteria, and that it manifests similarly in different regions of the world despite linguistic and cultural differences.
Authors: Dwight Dickinson; Terry E Goldberg; James M Gold; Brita Elvevåg; Daniel R Weinberger Journal: Schizophr Bull Date: 2010-03-29 Impact factor: 9.306
Authors: Minna Torniainen; Jaana Suvisaari; Timo Partonen; Anu E Castaneda; Annamaria Kuha; Jaana Suokas; Jonna Perälä; Samuli I Saarni; Jouko Lönnqvist; Annamari Tuulio-Henriksson Journal: J Nerv Ment Dis Date: 2012-04 Impact factor: 2.254
Authors: Rafael Tabarés-Seisdedos; Vicente Balanzá-Martínez; José Sánchez-Moreno; Anabel Martinez-Aran; José Salazar-Fraile; Gabriel Selva-Vera; Cristina Rubio; Ignacio Mata; Manuel Gómez-Beneyto; Eduard Vieta Journal: J Affect Disord Date: 2008-03-04 Impact factor: 4.839
Authors: Preethi Premkumar; Dominic Fannon; Elizabeth Kuipers; Michael A Cooke; Andrew Simmons; Veena Kumari Journal: Behav Brain Res Date: 2008-05-23 Impact factor: 3.332
Authors: Robert S Kern; Keith H Nuechterlein; Michael F Green; Lyle E Baade; Wayne S Fenton; James M Gold; Richard S E Keefe; Raquelle Mesholam-Gately; Jim Mintz; Larry J Seidman; Ellen Stover; Stephen R Marder Journal: Am J Psychiatry Date: 2008-01-02 Impact factor: 18.112
Authors: Timothea Toulopoulou; Xiaowei Zhang; Stacey Cherny; Dwight Dickinson; Karen F Berman; Richard E Straub; Pak Sham; Daniel R Weinberger Journal: Brain Date: 2019-02-01 Impact factor: 13.501
Authors: C Laidi; M-A d'Albis; M Wessa; J Linke; M L Phillips; M Delavest; F Bellivier; A Versace; J Almeida; S Sarrazin; C Poupon; K Le Dudal; C Daban; N Hamdani; M Leboyer; J Houenou Journal: Acta Psychiatr Scand Date: 2014-11-28 Impact factor: 6.392